- Home
- NNOX vs GOSS Comparison
NNOX vs GOSS Comparison
Compare NNOX & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NNOX
- GOSS
- Stock Information
- Founded
- NNOX 2011
- GOSS 2015
- Country
- NNOX Israel
- GOSS United States
- Employees
- NNOX N/A
- GOSS N/A
- Industry
- NNOX Medical Electronics
- GOSS Biotechnology: Pharmaceutical Preparations
- Sector
- NNOX Health Care
- GOSS Health Care
- Exchange
- NNOX Nasdaq
- GOSS Nasdaq
- Market Cap
- NNOX 305.7M
- GOSS 347.8M
- IPO Year
- NNOX 2020
- GOSS 2019
- Fundamental
- Price
- NNOX $4.65
- GOSS $1.76
- Analyst Decision
- NNOX Strong Buy
- GOSS Strong Buy
- Analyst Count
- NNOX 2
- GOSS 4
- Target Price
- NNOX $9.50
- GOSS $8.50
- AVG Volume (30 Days)
- NNOX 1.3M
- GOSS 3.6M
- Earning Date
- NNOX 08-12-2025
- GOSS 08-05-2025
- Dividend Yield
- NNOX N/A
- GOSS N/A
- EPS Growth
- NNOX N/A
- GOSS N/A
- EPS
- NNOX N/A
- GOSS N/A
- Revenue
- NNOX $11,545,000.00
- GOSS $40,237,000.00
- Revenue This Year
- NNOX $23.81
- GOSS N/A
- Revenue Next Year
- NNOX $149.38
- GOSS $63.97
- P/E Ratio
- NNOX N/A
- GOSS N/A
- Revenue Growth
- NNOX 15.32
- GOSS N/A
- 52 Week Low
- NNOX $3.75
- GOSS $0.66
- 52 Week High
- NNOX $11.00
- GOSS $2.23
- Technical
- Relative Strength Index (RSI)
- NNOX 39.35
- GOSS 50.44
- Support Level
- NNOX $4.50
- GOSS $1.91
- Resistance Level
- NNOX $4.95
- GOSS $2.23
- Average True Range (ATR)
- NNOX 0.21
- GOSS 0.18
- MACD
- NNOX -0.04
- GOSS -0.03
- Stochastic Oscillator
- NNOX 14.69
- GOSS 16.81
About NNOX NANO-X IMAGING LTD
Nano X Imaging Ltd is engaged in the business of manufacturing medical imaging systems. It offers a Nanox System which is a combination of hardware and software. It develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service. It has three business segments: Nanox.ARC division, the radiology services division and the AI solutions division. Key revenue is generated from Radiology Services.
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.